Mobile Menu

Invex Therapeutics Limited - Australian Company Profile

Enterprise Type: Public Company

ASX Code: IXC

What does Invex Therapeutics Limited do?

Invex Therapeutics is a Public Company that generates the majority of its income from the Scientific Research Services industry.

In 2024 the company generated total revenue of $1,704,000 including sales and other revenue. The exact number of employees for this organisation is not available.

The Chief Executive Officer of Invex Therapeutics is either not applicable or not available.The Chairman of Invex Therapeutics is Dr Jason Loveridge whose official title is Non-Executive Chairman.

Invex Therapeutics Limited - Products & Brands

Invex Therapeutics Limited is an ASX listed biopharmaceutical company. The company is engaged in the development of the following drug candidate: Exenatide – This drug candidate is approved for the treatment of type II diabetes but Invex is focused on reformulating it for the treatment of neurological conditions. The drug is trademarked as Presendin.

Invex Therapeutics Limited - Key Personnel

To view Invex Therapeutics Limited's full key personnel, see purchase options.

Invex Therapeutics Limited - Financial Statements

Invex Therapeutics Limited Financial Profit & Loss Account

BALANCE DATE 06/30/2024 06/30/2023 06/30/2022 06/30/2021 06/30/2020
Sales Revenue 0.0 0.0 0.0 0.0 0.0
Other Revenue
Total Revenue
Cost of Goods Sold
Depreciation
R & D Expenditure
To view all financial data for Invex Therapeutics Limited, see purchase options.

Invex Therapeutics Limited's Competitive Environment

Invex Therapeutics Limited operates in the following industries:

Invex Therapeutics Limited's main competitors:

To view all of Invex Therapeutics Limited's operating industries and competitors, see purchase options.

Looking for IBISWorld Industry Reports?

Gain strategic insight and analysis on 700+ Australian industries
(& thousands of global industries)

Enterprise Profiles - table of contents

Enterprise Details

Get a high-level overview of Invex Therapeutics Limited, including registered business details, an enterprise synopsis, SWOT analysis and main brands and products.

Key Personnel

We outline the key personnel at Invex Therapeutics Limited by position type and title.

Enterprise Financials

Get a full view of Invex Therapeutics Limited’s financials, including Profit and Loss Account (Revenue, Interest, Profit and Loss, and Audit Fees) and Balance Sheet (Current Assets, Non-Current Assets, Current Liabilities, Non-Current Liabilities, Shareholders’ Equity), as well as Number of Employees, Number of Share on Issue, Market Capitalisation and Earnings per Share where available. Note: we do not provide a full financial details for all company profiles.

Growth & Ratios

Get a clearer picture of Invex Therapeutics Limited’s performance, with key financial ratios and data on financial growth.

Operating Segments

Understand the main operating divisions of Invex Therapeutics Limited, including Revenue and Assets under each Segment, Industries and Geographic Locations Invex Therapeutics Limited operates in.

Competitor Benchmarking

Compare Invex Therapeutics Limited’s financial ratios and growth to peers in their industries of operation for a clearer picture of performance.

Major Shareholders

We outline the ultimate parent and largest shareholders of Invex Therapeutics Limited.

Subsidiaries

View a list of Invex Therapeutics Limited’s associated companies, holding company, joint ventures and trusts, both domestic and international.

History

Find out more about the history and background of Invex Therapeutics Limited, including founding information, past announcements, mergers and major projects.

Why buy this enterprise profile on Invex Therapeutics Limited?

IBISWorld enterprise profiles enable you to:

  • Understand a enterprise’s competitive landscape
  • Identify industry trends a enterprise is exposed to
  • Inform your decisions for marketing, strategy and planning
  • Target key enterprise personnel

The profile on BHP Group Limited includes:

  • Enterprise History and Synopsis
  • Overview of Brands and Products
  • Enterprise Financial Statements and Financial Ratios
  • Key Enterprise Personnel
  • Subsidiaries, Shareholders and Ownership Structure
  • Service Providers

IBISWorld provides profiles on thousands of leading enterprises across Australia and New Zealand, as well as reports on thousands of industries around the world. Our clients rely on our information and data to stay up-to-date on business and industry trends. Our expert reports are thoroughly researched, reliable and current, enabling you to make faster, better business decisions.

Purchase to read full report

100% Money Back Guarantee Digicert Trusted
Download Sample Report

Included in Report

  • Enterprise History & Synopsis Enterprise History & Synopsis
  • Enterprise Financial Statements Enterprise Financial Statements
  • Financial Ratios Financial Ratios
  • Industry Averages Industry Averages
  • Competitive Landscape Competitive Landscape
  • Key Enterprise Personnel Key Enterprise Personnel
  • Subsidiaries & Ownership Structure Subsidiaries & Ownership Structure

View Top 2,000 Companies

Trusted by More Than 10,000 Clients Around the World

  • IBISWorld client - VISA
  • IBISWorld client - ADP
  • IBISWorld client - Deloitte
  • IBISWorld client - AMEX
  • IBISWorld client - Bank of Montreal